Health

Business Wire Australia and New Zealand

AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activity in 2nd-Line EGFR Mutation-positive Lung Cancer with MET-amplification

17-Oct-2017 10:57 AM
  Data for savolitinib in combination with Tagrisso or Iressa presented at World Conference on Lung Cancer1,2 New data give insights into disease progression and potential next-generation treatment strategies in

Business Wire Australia and New Zealand

Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017

17-Oct-2017 9:28 AM
  In the STEPSTONE open-label study, ozanimod demonstrated meaningful clinical and endoscopic improvements in patients with moderately to severely active Crohn’s disease at week 12 In the TOUCHSTONE open-label extension study, ozan

Business Wire Australia and New Zealand

Takeda Presents Updated Results from Pivotal Phase 2 ALTA Trial of ALUNBRIGTM (brigatinib) in ALK-Positive Non-Small Cell Lung Cancer

16-Oct-2017 5:53 PM
- Updated Results Continue to Support the Efficacy and Safety Findings for ALUNBRIG with the 180 mg Dosing Regimen in Patients with Advanced ALK+ NSCLC Who Have Progressed on Crizotinib, Per Independent Review Committee: Median Progression-F

Business Wire Australia and New Zealand

FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB1

16-Oct-2017 7:56 AM
  Positive opinion is based on Phase III trial data demonstrating a 4.9 month progression-free survival improvement with combination over fulvestrant alone2 CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announced tha

Business Wire Australia and New Zealand

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Innovent Biologics, Inc. for Fully Human Monoclonal Antibody Drug Discovery

12-Oct-2017 3:45 PM
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human therapeutic monoclonal antibodies, to In

Philip Morris

Philip Morris announces commitment to smoke-free vision for Australia at federal inquiry

11-Oct-2017 4:06 PM
  5 October 2017 Philip Morris today announced that it is committed to pursuing a smoke-free future for Australia in which potentially reduced risk alternatives to smoking ultimately replace cigarettes. Appearing today before the Federa

Business Wire Australia and New Zealand

Orthocell Appoints Surgical Specialties as Exclusive Distributor

11-Oct-2017 11:16 AM
Surgical Specialties appointed as exclusive distributor in Australia and New Zealand of Orthocell’s world leading tendon regeneration (Ortho-ATI®) and cartilage regeneration therapy (Ortho-ACI®) Surgical Specialties has established 

Business Wire Australia and New Zealand

Ferring Strengthens Growth Hormone Franchise Zomacton® Through Acquisition of ZomaJet™ Needle-Free Injector Device

11-Oct-2017 9:33 AM
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc. to acquire the worldwide rights for the ZomaJet™ needle-free auto injector device. &n

Business Wire Australia and New Zealand

Wolters Kluwer Celebrates the 25th Anniversary of UpToDate with Launch of 25th Specialty, Anesthesiology

06-Oct-2017 9:17 AM
WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health announced today that UpToDate®, the acclaimed evidence-based clinical decision support (CDS) resource, is commemorating its 25th anniversary with the launch of its 25th&nbs

University of Auckland

Health workers urged to spot and help victims of slavery

05-Oct-2017 12:10 PM
UNDER EMBARGO UNTIL 5am FRIDAY 6 OCTOBER 2017

Business Wire Australia and New Zealand

CDISC Releases Therapeutic Area User Guide to Accelerate Development of Safer, More Effective Vaccines

05-Oct-2017 9:05 AM
AUSTIN, Texas--(BUSINESS WIRE)--The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the release of a new Therapeutic Area Standard for Vaccines in the form of a User Guide for data managers, statisticians, progra

Business Wire Australia and New Zealand

U.S. FDA Approves New Continued Access Protocol for the ReCell® Device for Treatment of Burn Injuries

04-Oct-2017 11:51 AM
Approval facilitates enrollment and allows participation of additional burn centers   VALENCIA, Calif. & PERTH, Australia & LONDON--(BUSINESS WIRE)--Avita Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company speciali

Business Wire Australia and New Zealand

NuGEN Introduces Unique Indexing Solutions for Illumina’s High Capacity Sequencing Platforms

04-Oct-2017 10:20 AM
SAN CARLOS, Calif.--(BUSINESS WIRE)--Today NuGEN Technologies announces a new line of indexing solutions designed to enable researchers to take full advantage of the latest generation of Illumina sequencers. The three new enhancemen

Business Wire Australia and New Zealand

Seattle Genetics and Takeda Announce Publication in Blood of Final Long-Term Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

04-Oct-2017 10:09 AM
    -Estimated Five-Year Overall Survival Rate was 60 Percent and Five-Year Progression-Free Survival Rate was 39 Percent- -In the 66 Percent of Patients who Achieved Complete Remission, Both Median Overall Survival and Progres

Business Wire Australia and New Zealand

Herbalife Nutrition Survey Reveals APAC Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging

03-Oct-2017 3:16 PM
Key findings of Herbalife Asia Pacific Healthy Aging survey (Graphic: Business Wire)   HONG KONG--(BUSINESS WIRE)--Premier global nutrition company, Herbalife (NYSE: HLF) today released findings from its Asia Pacific Healthy Agi

Business Wire Australia and New Zealand

Ferring Appoints Klaus Dugi as Executive Vice President and Chief Medical Officer

02-Oct-2017 4:53 PM
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today that Professor Klaus Dugi has been appointed Executive Vice President and Chief Medical Officer, effective immediately.   He will be responsible for Global

Business Wire Australia and New Zealand

Replicor Announces Publication of its REP 301 Study in HBV / HDV Co-Infection in The Lancet Gastroenterology & Hepatology

29-Sep-2017 9:36 AM
MONTREAL--(BUSINESS WIRE)--Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic HBV and hepatitis delta virus (HDV) co-infection, announced today the publication

Business Wire Australia and New Zealand

The Pink Ribbon Turns 25: The Estée Lauder Companies’ Breast Cancer Campaign Reaches 25 Year Milestone

29-Sep-2017 9:03 AM
Campaign honors the life and legacy of Evelyn H. Lauder, co-creator of the Pink Ribbon and champion of the breast cancer movement The Estée Lauder Companies raises $70 million to date and commits to its largest-ever fundraising goal The 2

Business Wire Australia and New Zealand

Avita Medical Announces Submission of U.S. FDA Premarket Approval (PMA) Application for the ReCell® Device for Treatment of Burn Injuries

28-Sep-2017 11:40 AM
VALENCIA, Calif. & PERTH, Australia & LONDON--(BUSINESS WIRE)--Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that it has submit

Business Wire Australia and New Zealand

Takeda to Feature ALUNBRIG™ (brigatinib) Data from Pivotal Phase 2 ALTA Trial at 18th World Conference on Lung Cancer

28-Sep-2017 10:44 AM
  - Presentations Include Updated Trial Data and Results from Additional Analyses in Crizotinib-Refractory ALK+ Non-Small Cell Lung Cancer – - Data Highlight Takeda’s Strengthened Oncology Business and Diversification of Pipeline into S